Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (2)

2021

  1. Safety and activity of the TGFβ receptor i kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2008

  1. Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer

    Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 52-57